title: The tolerability of sunitinib in elderly patients with metastatic renal cancer.
authors: Leggett Building, Oncology, University of Surrey, Guildford, UK.
authors: A
authors: A
authors: Michael
authors: Cancer Therapeutics Group, Mater Medical Research Institute, Mater Hospitals, South Brisbane, Australia.
authors: J
authors: J
authors: Coward
authors: Royal Surrey County Hospital, Guildford, UK.
authors: A
authors: A
authors: Brown
authors: Frimley Park Hospital, Frimley, UK.
authors: N
authors: N
authors: Barber
authors: Leggett Building, Oncology, University of Surrey, Guildford, UK.
authors: H
authors: H
authors: Pandha
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D020714:Maximum Tolerated Dose; D011379:Prognosis; D011758:Pyrroles / Q000627:therapeutic use*; D012189:Retrospective Studies; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib